Skip to main content
. 2021 Jan 27;39(10):1129–1138. doi: 10.1200/JCO.20.03288

FIG 2.

FIG 2.

Performance of the BL-IPI in the validation (international) cohort: (A) PFS according to BL-IPI risk group, (B) OS according to BL-IPI risk group; 3-year PFS and OS estimates are listed with 95% CIs (in parentheses); P values are from log-rank tests comparing groups sequentially and from an overall log-rank test. BL-IPI, Burkitt lymphoma International Prognostic Index; OS, overall survival; PFS, progression-free survival.